Abstract
Asthma is a generic, wastebasket term. It includes a group of complex, chronic inflammatory, multidimensional, markedly heterogeneous lung diseases that are similar enough to be lumped under the rubric “asthma.” This chapter summarizes our incomplete understandings about the causes, the disordered physiology, and the clinical variability of asthma; the principles of its diagnosis and treatment; and the need to move from usual to anticipatory care for best short- and long-term patient outcomes and costs. I will spend considerable space discussing asthma risk, severity, control, and treatment responsiveness because these concepts interact in guiding asthma management for individual patients and populations. I conclude by describing a system-based approach we have developed at Advocate Health Care that has improved outcomes for our urban patients with high-risk asthma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3. Guidelines for the Diagnosis and Management of Asthma. Full report 2007. Bethesda MD: U.S. Department of Health and Human Services, 2007; NIH publication no. 07–4051.
Singh AM, Busse WW. Asthma exacerbations – 2: Aetiology. Thorax. 2006;61(9):809–16.
Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315–23.
Quinn K, Shalowitz MU, Berry CA, et al. Racial and ethnic disparities in diagnosed and possible undiagnosed asthma among public-school children in Chicago. Am J Public Health. 2006;96(9):1599–603.
Woolf SH, Grol R, Hutchinsonn A, et al. Potential benefits, limitations, and harms of clinical guidelines. Br Med J. 1999;318(7182):527–30.
Calhoun WJ, Sutton BB, Emmett A, et al. A variability in patients previously treated with ß-agonists alone. J Allergy Clin Immunol. 2003;112(6):1088–94.
Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization consultation on severe asthma. J Allergy Clin Immunol. 2010;126(5):926–38.
Haahtela T, Jävinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994;331(11):700–5.
Centers for Disease Control and Prevention. National Center for Health Statistics. National Vital Statistics Report. Deaths: Final Data for 1999–2006. Trends in asthma morbidity and mortality. American Lung Association, Epidemiology and Statistics Unit, Research and Program Services Division. February, 2010.
Foggs MB. Influence of socioeconomic status, race, and clinical environment on asthma care. Respir Digest. 2005;7(2):1–13.
Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Ann Int Med. 1999;130(6):487–95.
Chung KF, Godard P, Adelroth E, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS task force on difficult/therapy-resistant asthma. European Respiratory Society. Eur Respir J. 1999;13(5):1198–208.
Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med. 2005;172(2):149–60.
Bach PP, Pham HH, Schrag D, et al. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351(6):575–84.
Halm EA, Mora P, Leventhal H. No symptoms, no asthma: the acute episodic disease belief is associated with poor asthma self-management among inner-city adults with persistent asthma. Chest. 2006;129(3):573–80.
Patel PH, Welsh C, Foggs MB. Improved asthma outcomes using a coordinated care approach in a large medical group. Disease Manage. 2004;7(2):102–11.
Evans R, LeBailly S, Gordon KK, et al. Restructuring asthma care in a hospital setting to improve outcomes. Chest. 1999;116(4 Suppl 1):210S–6S.
Jones CA, Clement LT, Harley-Lopez J, et al. The Breathmobile program: structure, implementation, and evolution of a large-scale urban pediatric asthma disease management program. Disease Manage. 2005;8(4):205–22.
Foggs MB. Guidelines management of asthma in a busy urban practice. Curr Opin Pulm Med. 2008;14(1):46–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Foggs, M.B. (2012). Asthma: Identifying and Treating High-Risk Patients. In: Harrington, J., Newman, E. (eds) Great Health Care. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1198-7_18
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1198-7_18
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-1197-0
Online ISBN: 978-1-4614-1198-7
eBook Packages: MedicineMedicine (R0)